REGENXBIO Inc. (RGNX) Profit Margins
Over the twelve months to 2026-06-30, REGENXBIO Inc. (RGNX) had operating margin -94.1%, net margin -112.6%, free cash flow margin -143.1%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RGNXREGENXBIO Inc.Follow RGNX — free
—
Price chart with a free account
- Market cap
- 441.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 17 days
| Line | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 98.7% | 97.9% | 99.9% | — | 76.6% | 76.9% | 89.0% | 51.6% | 59.7% | — | — | |
| Operating margin | -304.9% | -1423.8% | -730.2% | 40.3% | -422.9% | -77.1% | 34.0% | -233.2% | -280.0% | -94.6% | -94.1% | |
| Net margin | -300.6% | -1372.1% | -704.0% | 45.7% | -268.9% | -72.0% | 27.2% | -248.7% | -272.5% | -113.8% | -112.6% | |
| FCF margin | -303.6% | -1235.7% | -626.9% | 41.8% | -339.0% | -52.4% | 28.6% | -211.3% | -210.7% | -74.1% | -143.1% |
USD billions · SEC XBRL
REGENXBIO Inc. — questions
- What is REGENXBIO Inc.'s operating margin?
- -94.1% over the twelve months to 2026-06-30.
- What is REGENXBIO Inc.'s net profit margin?
- -112.6% over the twelve months to 2026-06-30.
Every figure on this page comes from REGENXBIO Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.